CVS Health is asking drugmakers not to increase the total cost of their drugs if rebates go away, according to a letter obtained by Business Insider.
Pharmaceutical company executives prepare to testify before the Senate Finance Committee hearing on drug prices.CVS Health is asking drugmakers not to increase the net cost of their drugs should rebates go away, according to a letter obtained by Business Insider.
A little-known practice that healthcare middlemen use to negotiate drug prices might go away, and one of the biggest company's in the space is bracing for it., which operates the pharmacy benefit manager CVS Caremark, wrote to drugmakers asking them not to increase the total cost of their drugs, should payments they typically make to PBMs as rebates go away as part of a proposed rule from the Trump administration.
But it could also benefit big drugmakers. The pharmaceutical industry, for its part, has said it supports curbing rebates. In a recent congressional hearing on drug pricing, pharmaceutical CEOs were asked about the proposed change and indicated clear support for the proposal. CVS gave an example of a $100 drug on which a drugmaker had a $20 rebate. In today's model, that would lead to an $80 net cost for the drug. CVS says that should the $20 rebate go away, the company would like to see the net cost stay at $80, instead of increasing to $100.
इंडिया ताज़ा खबर, इंडिया मुख्य बातें
Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।
CVS Health CEO on reducing costs: Billions in value opportunity is 'in front of us'Jim Cramer talks with CVS CEO Larry Merlo, who says reducing medical costs with the Aetna merger will unlock billions of dollars in value for the company.
और पढो »
Analysis | The Health 202: Hospitals lean into virtual health care even as Medicare won't cover itTelehealth advocates say it's not only rural areas that lack access to health providers.
और पढो »
Doctor App Babylon Health Offers Quick Appointments, But Grapples With Follow-Up Care For Mental HealthA third of London’s mental-health providers are rejecting patient referrals from Babylon Health, a video-calling service used by thousands. Former staff say the startup is struggling to plug into Britain’s healthcare system.
और पढो »
Doctor App Babylon Health Offers Quick Appointments, But Grapples With Follow-Up Care For Mental HealthA third of London’s mental-health providers are rejecting patient referrals from Babylon Health, a video-calling service used by thousands. Former staff say the startup is struggling to plug into Britain’s healthcare system.
और पढो »
Curaleaf shines in falling cannabis sector on news of surprising CVS dealCannabis stocks were mostly lower Thursday, with Curaleaf Holdings Inc. a standout after announcing a partnership with drugstore chain CVS Health Corp. on a...
और पढो »
CVS to sell CBD products over-the-counter as an 'alternative source of relief'CVS Pharmacy announced it will begin selling hemp-derived CBD products in 8 states. The items, such as cannabidiol-infused creams, sprays, and roll-ons, will be offered as “an alternative source of relief,” the company said in a statement.
और पढो »
Curaleaf is putting CBD in one of the biggest drugstore chains in the U.S.U.S. cannabis retailer Curaleaf Holdings Inc. said late Wednesday that it has inked a deal with CVS Health Corp. to carry its line of cannabidiol, or CBD,...
और पढो »
CVS has started selling cannabis-based products in 8 statesThe pharmacy chain said the products include topicals such as creams, sprays, roll-ons, lotions and salves.
और पढो »
CVS heard from its customers who use CBD, will 'walk slowly' in the space, CEO Larry Merlo saysCVS has started selling CBD, short for cannabidiol products, in eight states. CEO Larry Merlo said CVS will 'walk slowly.'
और पढो »
CBD is being sold at the largest drugstore chain in the U.S.U.S. cannabis retailer Curaleaf Holdings Inc. said late Wednesday that it has inked a deal with CVS Health Corp. to carry its line of cannabidiol, or CBD,...
और पढो »